News | December 10, 2007

Replacement Heart Valve Technology Wins Venture Showcase Award

December 11, 2007 - ValveXchange, developer of a next-generation replacement heart valve technology, won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 Conference & Expo in Denver.
The Venture Showcase Award was provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards Luncheon.

ValveXchange holds patented technology on a two-piece bioprosthetic tissue valve that reportedly resolves the compromises between conventional mechanical and tissue heart valves. ValveXchange has exclusively licensed its core technology, invented by founder Ivan Vesely, PhD, from The Cleveland Clinic Foundation. Funding from the founder and three SBIR grants has allowed for prototypes developed with proof of concept, two-piece exchangeable tissue valve, functional & mechanical tests, in vitro testing of prototypes, validated performance and in vivo testing. The company says it is initiating recruitment of Angel and Series A Financing of $2.5 million to bring the technology to the clinical trial stage.

For more information: www.valvexchange.com

Related Content

Technology | Heart Valve Technology | July 18, 2018

Abbott Receives FDA Approval for Third-Generation MitraClip Device

July 18, 2018 — Abbott announced it received approval from the U.S.

Videos | Heart Valve Technology | July 18, 2018

VIDEO: The Essentials of CT Transcatheter Valve Imaging

Jonathon Leipsic, M.D., FSCCT, professor of radiology and cardiology at the University of British Columbia, Vancouver

Videos | Heart Valve Technology | July 10, 2018

VIDEO: Tricuspid Device Clinical Trial Overview

Ori Ben-Yehuda, M.D., executive director of the Cardiovascular Research Foundation Clinical Trial Center, discusses t

Videos | Heart Valve Technology | July 05, 2018

VIDEO: Tricuspid Valve Imaging and Interventions Developing Hand-in-hand

Rebecca Hahn, M.D., professor of medicine and director of interventional echocardiography, Columbia University Medica

Henry Ford Hospital First in Michigan to Perform Cardioband Mitral Valve Procedure

An angiography image showing the catheter-based implantation of the Cardioband annuloplasty ring using corkscrew shaped anchors.

News | Heart Valve Technology | June 13, 2018

Henry Ford Hospital First in Michigan to Perform Cardioband Mitral Valve Procedure

Henry Ford Hospital is one of 17 U.S. trial sites using a catheter-based procedure approved in Europe to repair a leaky...

Abbott Portico transcatheter aortic valve replacement (TAVR) performed well PORTICO I real-world study. #EuroPCR

News | Heart Valve Technology | June 01, 2018

Portico TAVR System Reduces Severe Aortic Stenosis at 30 Days in Real-World Setting

June 1, 2018 – Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with e

News | Heart Valve Technology | May 25, 2018

Tendyne Transcatheter Mitral Valve Replacement Device Demonstrates Positive 30-Day Outcomes

Abbott announced favorable outcomes from the first 100 patients treated in a global study of its Tendyne Transcatheter...

A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.

A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.

Feature | Heart Valve Technology | May 14, 2018

Length of Stay Impacts TAVR Outcomes

May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-femor

The use of 3-D printed hearts from patients' pre-TAVR planning CT scans have improved outcomes of procedures at the University of Minnesota. Clearly identifying where calcium is located on the valves prior to TAVR device implantation has helped reduce the incidence of paravalvular leak. #SCAI, #SCAI2018

The use of 3-D printed hearts from patients' pre-TAVR planning CT scans have improved outcomes of procedures at the University of Minnesota. Clearly identifying where calcium is located on the valves prior to TAVR device implantation has helped reduce the incidence of paravalvular leak.

News | Heart Valve Technology | May 14, 2018

3-D Printed Models to Guide TAVR Improve Outcomes

May 14, 2018 – A new study examines the effectiveness of 3-D printing technology and computer modeling to predict par

News | Heart Valve Technology | May 11, 2018

First-Ever Risk Tool Helps Predict TAVR Readmission Rates

A new study looked at the effectiveness of a novel risk tool to predict 30-day readmission rates in patients undergoing...